Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.
P/E ratio for Augmedix, Inc. (AUGX)
P/E ratio as of 2023: -13.41
According to Augmedix, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -13.41. At the end of 2022 the company had a P/E ratio of -2.20.
P/E ratio history for Augmedix, Inc. from 2018 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -13.41 |
| 2022 | -2.20 |
| 2021 | -5.31 |
| 2020 | -2.39 |
| 2019 | -0.19 |
| 2018 | -0.25 |